SignatureFD’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.99M | Buy |
16,893
+588
| +4% | +$296K | 0.12% | 61 |
|
|
2025
Q4 | $7.61M | Sell |
16,305
-379
| -2% | -$176K | 0.12% | 63 |
|
|
2025
Q3 | $7.11M | Sell |
16,684
-762
| -4% | -$295K | 0.11% | 65 |
|
|
2025
Q2 | $6.68M | Buy |
17,446
+14,227
| +442% | +$5.13M | 0.11% | 63 |
|
|
2025
Q1 | $1.11M | Buy |
3,219
+319
| +11% | +$103K | 0.02% | 310 |
|
|
2024
Q4 | $871K | Sell |
2,900
-255
| -8% | -$89.1K | 0.02% | 370 |
|
|
2024
Q3 | $1.28M | Buy |
3,155
+133
| +4% | +$48.7K | 0.02% | 265 |
|
|
2024
Q2 | $971K | Buy |
3,022
+150
| +5% | +$48.7K | 0.02% | 310 |
|
|
2024
Q1 | $958K | Buy |
2,872
+63
| +2% | +$19.3K | 0.02% | 320 |
|
|
2023
Q4 | $760K | Sell |
2,809
-61
| -2% | -$15.1K | 0.02% | 355 |
|
|
2023
Q3 | $706K | Sell |
2,870
-3
| -0.1% | -$821 | 0.02% | 335 |
|
|
2023
Q2 | $872K | Buy |
2,873
+57
| +2% | +$15.8K | 0.02% | 284 |
|
|
2023
Q1 | $743K | Buy |
2,816
+151
| +6% | +$38.4K | 0.02% | 313 |
|
|
2022
Q4 | $639K | Buy |
2,665
+255
| +11% | +$57.1K | 0.02% | 335 |
|
|
2022
Q3 | $443K | Buy |
2,410
+322
| +15% | +$64.1K | 0.02% | 409 |
|
|
2022
Q2 | $351K | Sell |
2,088
-197
| -9% | -$42.3K | 0.01% | 475 |
|
|
2022
Q1 | $573K | Buy |
2,285
+247
| +12% | +$62K | 0.02% | 363 |
|
|
2021
Q4 | $524K | Sell |
2,038
-7
| -0.3% | -$1.71K | 0.02% | 379 |
|
|
2021
Q3 | $496K | Buy |
2,045
+256
| +14% | +$62.6K | 0.02% | 371 |
|
|
2021
Q2 | $370K | Buy |
1,789
+151
| +9% | +$30.8K | 0.01% | 454 |
|
|
2021
Q1 | $309K | Buy |
1,638
+153
| +10% | +$27K | 0.01% | 439 |
|
|
2020
Q4 | $244K | Sell |
1,485
-13
| -0.9% | -$1.9K | 0.01% | 474 |
|
|
2020
Q3 | $187K | Buy |
1,498
+2
| +0.1% | +$248 | 0.01% | 501 |
|
|
2020
Q2 | $145K | Sell |
1,496
-104
| -7% | -$10.8K | 0.01% | 550 |
|
|
2020
Q1 | $144K | Buy |
1,600
+275
| +21% | +$35.6K | 0.01% | 512 |
|
|
2019
Q4 | $196K | Sell |
1,325
-259
| -16% | -$34.8K | 0.01% | 472 |
|
|
2019
Q3 | $191K | Sell |
1,584
-21
| -1% | -$2.71K | 0.02% | 426 |
|
|
2019
Q2 | $217K | Sell |
1,605
-258
| -14% | -$32.6K | 0.02% | 369 |
|
|
2019
Q1 | $243K | Buy |
1,863
+323
| +21% | +$43.4K | 0.02% | 335 |
|
|
2018
Q4 | $192K | Sell |
1,540
-1,091
| -41% | -$146K | 0.02% | 378 |
|
|
2018
Q3 | $366K | Buy |
2,631
+1,540
| +141% | +$192K | 0.04% | 262 |
|
|
2018
Q2 | $112K | Buy |
1,091
+86
| +9% | +$8.7K | 0.01% | 578 |
|
|
2018
Q1 | $97K | Buy |
+1,005
| New | +$97.5K | 0.01% | 544 |
|
|
2016
Q4 | – | Sell |
-501
| Closed | -$38K | – | 643 |
|
|
2016
Q3 | $38K | Sell |
501
-18
| -3% | -$1.38K | 0.01% | 604 |
|
|
2016
Q2 | $40K | Buy |
519
+64
| +14% | +$5.05K | 0.01% | 526 |
|
|
2016
Q1 | $36K | Buy |
455
+357
| +364% | +$24.9K | 0.01% | 513 |
|
|
2015
Q4 | $7K | Sell |
98
-4,719
| -98% | -$329K | ﹤0.01% | 802 |
|
|
2015
Q3 | $373K | Buy |
4,817
+286
| +6% | +$25.3K | 0.09% | 78 |
|
|
2015
Q2 | $411K | Sell |
4,531
-994
| -18% | -$79.6K | 0.09% | 77 |
|
|
2015
Q1 | $416K | Buy |
5,525
+725
| +15% | +$52.1K | 0.1% | 76 |
|
|
2014
Q4 | $352K | Buy |
+4,800
| New | +$337K | 0.09% | 91 |
|
Other funds holding HCA
VCM
VPM
SignatureFD's HCA Position: Q1 2026 in Review
SignatureFD increased its HCA Healthcare (HCA) stake by 3.6% in Q1 2026, buying an estimated $296K and bringing the position to 16,893 shares worth $7.99M. The position accounts for 0.12% of the portfolio, ranked #61.
SignatureFD first reported a position in HCA in Q4 2014 and has held it in 41 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- SignatureFD held 16,893 shares of HCA Healthcare worth $7.99M as of Q1 2026.
- SignatureFD bought 588 HCA Healthcare shares in Q1 2026, an estimated $296K.
- HCA Healthcare made up 0.12% of SignatureFD's portfolio in Q1 2026, its #61 holding.
- SignatureFD first reported a position in HCA Healthcare in Q4 2014 and has held it in 41 quarters since.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.